Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt
Review

Natural killer cells in ovarian cancer therapy: mechanisms, evasion, and therapeutic innovations.

Wei-Hong Long Cai-Yun Zhang Can Zhang Jun-Jie Ni Chao-Liang Xiong Xu Wu Ming-Xing Li Fukuan Du Yu Chen Yueshui Zhao Jing Shen Hin-Cho Chi Zhangang Xiao
Sep 2026 · InflammoPharmacology · 0 citations · 126 references
Medicine

TL;DR

The mechanisms involved in NK cells in ovarian cancer treatment, the current status of clinical applications, and new research strategies in the future are summarized to provide a reference for the development of research and clinical practice in this field.

DOI PubMed Semantic Scholar
View source

Similar papers

Review Open access Sep 2026

The evolving role of immunotherapy in ovarian cancer

Research directions to make ovarian cancer more susceptible to immunotherapy are moving from empiric treatment to more biologically informed, multimodal approaches aimed at overcoming immune suppression, enhancing antitumor immunity, and personalizing treatment for patients with ovarian cancer.

A. Veneziani, Laura Venegas, A. Oza · 0 citations
Review Open access 2026

Genetic medicine in cancer treatment: CAR T-сell therapy (a literature review)

Cancer remains one of the leading causes of fatal outcome worldwide. Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapeutic approach to cancer treatment based on the use of cytotoxic lymphocytes engineered to express chimeric antigen receptors. CAR T-cell therapy involves collecting T-cells from a patie...

K. Aitbayev, I. Murkamilov, V. V. Fomin et al. · 0 citations
Review Open access Aug 2026

Ovarian cancer tumor immune microenvironment and its clinical trial implications

This narrative educational review aims to provide a comprehensive overview of recent advances in the understanding of ovarian cancer pathogenesis, the molecular mechanisms driving tumor progression, and the multifaceted role of the immune system in disease development and therapeutic response.

B. Vavrušáková, R. Bartošová, M. Hendrych et al. · 0 citations
Review Aug 2026

Systemic therapy-induced resistance and toxicity in breast cancer: Sensitization and mitigation strategies.

This review uncovers recent updates on acquired resistance mechanisms toward standard-of-care treatments driven by deeply rooted heterogeneity and aggressive nature and helps to identify novel strategies targeting pathways to reverse resistance and reduce toxicity in breast cancer patients.

Anuveda Sree Samudrala, G. Nagaraju, RamaRao Malla · 0 citations
Review Open access Aug 2026

Breast Cancer CDK4/6 Inhibitor Resistance and Immunotherapy Strategies

Two main ways in which CDK4/6 inhibitors exert their effects are reviewed, one is to directly block the cell cycle, and the other is to reshape the immune microenvironment.

Qi-Ya Jing · 0 citations
Open access Sep 2026

Immunomodulatory Potential of KSTM in Activating Natural Killer Cells for Cancer Cell Elimination

Background/Objectives: Cancer remains a major cause of mortality worldwide, and resistance to therapy continues to limit treatment success. Improving the susceptibility of cancer cells to immune-mediated killing, particularly by natural killer (NK) cells, may enhance therapeutic outcomes. This study aimed to determine...

Tanyarat Pianmak, A. Panya, Natthanich Boonsatit et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.